The Cycling News forum is still looking to add volunteer moderators with. If you're interested in helping keep our discussions on track, send a direct message to
In the meanwhile, please use the Report option if you see a post that doesn't fit within the forum rules.
Thanks!
Tour of Switzerland is 9 days only. Could be managed with strict restrictions. That would / might be the major tour of the year then, as I don't see neither the Tour de France or the Giro d’Italia running at the moment!
I think May is possible, but June is more likely. With hope of a treatment possibly coming in May that should get things better by June. Also at some point we have to get to a saturation point.
Where did you read this?
Voted July. At one point countries will have to decide whether the negative effects of isolation on economy and society are bigger than the ones that Corona brings. But the races can't be organised just like bam, so I suppose still after that it will take some time until they start again, and then it probably won't be the biggest ones but rather some one-day-races. Pure speculation.![]()
Gilead and one other company have treatment in clinical testing currently with the hope of good results in early may. The other company it's a malaria drug that is currently in production with Gilead it's a drug they developed for a different outbreak. The hope is if all goes perfectly the drug can get approved and to market by May. The hopeful May time frame was mentioned on CNBC the other day. This requires everything to go prefect and get everything fast tracked. They are currently using it in Washington (state).
![]()
Gilead coronavirus treatment already being used in Washington state
According to CDC director Dr. Robert Redfield in congressional testimony.fortune.com
Here's another article. It's experimental but appears to already be being used in other viruses that are similar to this one. Hence the reason for the hope.
![]()
Hopes rise over experimental drug's effectiveness against coronavirus
Many see remdesivir as one of few drugs that has reasonable prospect of helping patientswww.theguardian.com
Here's one more:
![]()
These 23 companies are working on coronavirus treatments or vaccines — here’s where things stand
A mix of legacy drugmakers and small startups have stepped forward with plans to develop vaccines or treatments that target the infection caused by the novel...www.marketwatch.com
Type: Treatment
Stage: Phase 3 clinical trials
Name: remdesivir
Background: Gilead is a longtime drug maker that is best known for developing the first major cure for hepatitis-C in Sovaldi, a therapy that changed the standard of care for that disease but also kicked off the national debate about drug pricing. The company has experience developing and marketing HIV drugs, including Truvada for pre-exposure prophylaxis (PrEP), its preventive HIV medicine. Along with U.S. trials, Gilead is conducting a randomized, controlled clinical trial in Wuhan, testing remdesivir as a treatment for mild to moderate forms of pneumonia in people with the virus. The trial was given the go-ahead by China’s Food and Drug Administration in February.
Clinical trials:
1. On Feb. 21, the National Institute of Allergy and Infectious Diseases started enrolling patients in a randomized, double-blind, placebo-controlled Phase 3 trial evaluating 394 hospitalized patients with COVID-19 at up to 50 sites worldwide. The trial is expected to conclude April 1, 2023. Sites include the National Institutes of Health in Bethesda, Md., (not recruiting), the University of Nebraska Medical Center in Omaha (recruiting), the University of Texas Medical Branch in Galveston (not recruiting), and Providence Sacred Heart Medical Center in Spokane (recruiting).
2. On March 3, Gilead said a randomized, open-label Phase 3 trial will evaluate remdesivir in 600 patients with moderate COVID-19. The trial is expected to start enrolling patients in March, with results to come in May.
3. On March 3, Gilead said a randomized, open-label Phase 3 trial will evaluate remdesivir in 400 patients with severe COVID-19. The trial is expected to start enrolling patients in March, with results in May.
They are treating in the Seattle, Washington area.
They are using remdesivir in Italy. Not working greatly.
They have found that there's also tocilizumab that's used for arthritis that looks promising.
Still no real cures as of now.
So, while we hope for the best, the truth is everything will be put in lockdown for quite a lot of time.